About: Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. The company is also developing etripamil for the indication of atrial fibrillation with rapid ventricular rate (AFib-RVR). It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.76 (-0.92%)
MIST NASDAQ Milestone Pharmaceuticals Inc
Milestone Pharmaceuticals Inc share price
MIST price activity
Last Price
$0.760
Change (24hr)
-0.01 USD (-0.92%)
Volume
882.87K
Volume (4w avg)
-
Open
$0.76
Day Range
$0.73 - $0.77
Previous Close
$0.76
Last Trade
07 Oct, 8:27 pm GMT+0
Delayed
07 Oct, 8:27 pm GMT+0
MIST price performance
Delayed
07 Oct, 8:27 pm GMT+0
MIST Market Signals